Tuesday, March 17, 2026

OFFICE FOR PROFIT: Trump’s Insane Wealth Surge Proves The Presidency Is For Sale To His Family

Cryptocurrency prices have plummeted, yet Trump-themed coins surge, raising concerns about political influence and profit motives.

Netflix’s ‘KPop Demon Hunters’ OST Dominates U.S. Charts With Record-Breaking Run

The OST of Netflix's KPop Demon Hunters tops charts in the US and UK, showcasing the global rise of K-pop music.

NVIDIA Surges Again! Stock Hits $123.51 as AI Hype Grows!

NVIDIA surged over 2% following a positive report from Bain & Company, reclaiming a market capitalization of $3 trillion.

Tag: Therapeutics

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Verismo Therapeutics Welcomes FDA Approval Expert Dennis Williams: What This Means for CAR-T Cell Therapy

HLB Innovation appoints Dr. Dennis Williams as VP of Regulatory Affairs at Verismo Therapeutics to enhance global regulatory strategies.

How JNPMEDI Plans to Achieve 250% Revenue Growth in 2026: A Guide for Pharma Innovators

JNPMEDI aims to enhance its global role in drug and medical device development, achieving significant growth and expanding partnerships.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.